Answer: a, c Immediate hemolytic reactions are usually caused by blood group ABO incompatibility although they may be caused by antigens of other blood group systems on the transfused red blood cells. The clinical manifestations revolve around the antigen on the red blood cell stroma and the antibody in the patient’s serum, and include production of bradykinin, compliment activation, release of vasoactive agents from platelets, and initiation of systemic clotting. Chills and fevers, chest pain and lumbar pain, tachycardia and hypotension in the conscious patient, and often diffuse bleeding in the anesthetized, unconscious patient constitute this syndrome. Although reaction occurs immediately, death related to the syndrome is uncommon, unless associated with a transfusion of more than 100 ml of blood. Death usually occurs from acute renal failure or hemorrhage due to DIC. Nonhemolytic reactions occur with the frequency of 1 to 2% of all transfusions and consist primarily of chills and fevers during the transfusion or in the first 2 to 3 hours after the transfusion is complete. Mechanism of these reactions includes the presence of antibodies to white blood cell antigens in the transfused blood, especially in the multitransfused or multiparous patient. Massive transfusion complications relate to the rate and volume of blood transfused. The most common complication is dilutional thrombocytopenia. Factor deficiency of the labile factors V and VIII rarely is of sufficient magnitude to result in problems with hemostasis. For hypocalcemia to occur with massive transfusion, citrated blood must be administered, one unit every five minutes. Routine empiric calcium supplementation is unnecessary during most massive transfusion episodes. Conversely, hypothermia is clearly a problem, especially when associated with massive transfusion during complex intraoperative procedures such as thoracoabdominal aneurysm resection